Interferon-beta

Managing MS relapses during pregnancy 2:25
Managing MS relapses during pregnancy
Kristen Krysko • 4 Apr 2022
COVID booster vaccines do not lead to humoral responses in patients with MS treated with DMTs 1:57
COVID booster vaccines do not lead to humoral responses in patients with MS treated with DMTs
Celia Oreja-Guevara • 24 Feb 2022
How to approach MS treatment sequencing in a crowded therapeutic market 1:13
How to approach MS treatment sequencing in a crowded therapeutic market
Jeffrey Cohen • 24 Feb 2022
A score to predict treatment response in pediatric patients with multiple sclerosis 3:26
A score to predict treatment response in pediatric patients with multiple sclerosis
Ermelinda De Meo • 27 Oct 2021
Humoral response to COVID-19 vaccination in patients with MS 6:28
Humoral response to COVID-19 vaccination in patients with MS
Celia Oreja-Guevara • 14 Oct 2021
Challenges with COVID-19 & MS registries 3:04
Challenges with COVID-19 & MS registries
Maria Pia Sormani • 13 Oct 2021
Update on pediatric NMOSD and MOGAD 3:47
Update on pediatric NMOSD and MOGAD
Brenda Banwell • 26 Apr 2021
DMTs and risk for severe COVID-19 in multiple sclerosis patients 2:51
DMTs and risk for severe COVID-19 in multiple sclerosis patients
Maria Pia Sormani • 6 Apr 2021
Immunomodulatory effects of vitamin D in MS 3:13
Immunomodulatory effects of vitamin D in MS
Jorge Correale • 5 Mar 2021
The problem with defining types of MS 3:10
The problem with defining types of MS
Gavin Giovannoni • 19 Oct 2020
Therapeutic options in multiple sclerosis 4:08
Therapeutic options in multiple sclerosis
Celia Oreja-Guevara • 24 May 2020
The content of VJNeurology is intended for healthcare professionals